UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

P932 Corticosteroid-sparing effect of mirikizumab for the treatment of moderately-to-severely active Ulcerative Colitis: Extended induction subgroup analysis from Phase 3 trial

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1697-i1698

2024

Link zum Volltext

Verfügbarkeit prüfen

Antenatal and perinatal factors influencing neonatal blood pressure: a systematic review

Journal of perinatology, 2021-09, Vol.41 (9), p.2317-2329

2021

Link zum Volltext

Verfügbarkeit prüfen

P901 Extended induction response over time in patients with moderately-to-severely active Ulcerative Colitis treated with mirikizumab in the LUCENT-1 and -2 trials

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1651-i1652

2024

Link zum Volltext

Verfügbarkeit prüfen

OP14 Effect of mirikizumab on clinical and endoscopic outcomes after 1 anti-TNF failure in patients with moderately to severely active Ulcerative Colitis

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i27-i28

2024

Link zum Volltext

Verfügbarkeit prüfen

P568 Clinical relevance of baseline and change in Urgency Numeric Rating Scale score for mirikizumab treatment for Ulcerative Colitis

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1109-i1111

2024

Link zum Volltext

Verfügbarkeit prüfen

108 Impact of Endogenous Hormonal Status on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5mg for LUTS/BPH

Journal of sexual medicine, 2016-05, Vol.13 (5), p.S51-S52

2016

Link zum Volltext

Verfügbarkeit prüfen

778 Satisfaction with tadalafil or tamsulosin once daily for the treatment of LUTS/BPH: Treatment satisfaction scale questionnaire results from a randomized double-blind, placebo-controlled trial

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e778-e778

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological treatment of women awaiting Surgery for stress urinary incontinence

Obstetrics and gynecology (New York. 1953), 2004-09, Vol.104 (3), p.511-519

2004

Link zum Volltext

Verfügbarkeit prüfen

Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial

The American journal of cardiology, 2002-12, Vol.90 (11), p.1204-1210

2002

Link zum Volltext

Verfügbarkeit prüfen

Method of Blood Pressure Measurement in Neonates and Infants: A Systematic Review and Analysis

The Journal of pediatrics, 2020-06, Vol.221, p.23-31.e5

2020

Link zum Volltext

Verfügbarkeit prüfen

S917 Mirikizumab Achieved Comprehensive Disease Control in Patients With Ulcerative Colitis From Phase 3 LUCENT-1 and LUCENT-2 Trials

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S684-S685

2023

Link zum Volltext

Verfügbarkeit prüfen

S913 The Addition of Bowel Urgency Improvement to the Achievement of Clinical Response and Remission Was Associated with Better Quality of Life in Patients with Ulcerative Colitis from Mirikizumab Phase 3 Trials

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S681-S682

2023

Link zum Volltext

Verfügbarkeit prüfen

S915 The Addition of Bowel Urgency Improvement to the Achievement of Clinical Response or Remission Was Associated with Better Work Productivity in Patients with Ulcerative Colitis from Mirikizumab Phase 3 Trials

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S682-S683

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials

Journal of headache and pain, 2019-07, Vol.20 (1), p.84-84, Article 84

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH): results from a randomised, placebo‐controlled study

BJU international, 2014-10, Vol.114 (4), p.568-575

2014

Link zum Volltext

Verfügbarkeit prüfen

Tolerability and Safety of Lasmiditan Treatment in Elderly Patients With Migraine: Post Hoc Analyses From Randomized Studies

Clinical therapeutics, 2021-06, Vol.43 (6), p.1066-1078

2021

Link zum Volltext

Verfügbarkeit prüfen

Migraine history and response to lasmiditan across racial and ethnic groups

Current medical research and opinion, 2022-05, Vol.38 (5), p.721-730

2022

Link zum Volltext

Verfügbarkeit prüfen

Time to Onset of Clinically Meaningful Improvement with Tadalafil 5 mg Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Analysis of Data Pooled from 4 Pivotal, Double-Blind, Placebo Controlled Studies

The Journal of urology, 2015-05, Vol.193 (5), p.1581-1589

2015

Link zum Volltext

Verfügbarkeit prüfen

Lasmiditan in patients with common migraine comorbidities: a post hoc efficacy and safety analysis of two phase 3 randomized clinical trials

Current medical research and opinion, 2020-11, Vol.36 (11), p.1791-1806

2020

Link zum Volltext

Verfügbarkeit prüfen

A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN

Journal of headache and pain, 2021-12, Vol.22 (1), p.101-101, Article 101

2021

Link zum Volltext

Verfügbarkeit prüfen

Lasmiditan efficacy in migraine attacks with mild vs. moderate or severe pain

Current medical research and opinion, 2021-06, Vol.37 (6), p.1031-1038

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparability of Single Measurements of Serum Testosterone to the 24‐Hour Cavg in Patients Using Testosterone 2% Solution

Journal of sexual medicine, 2014-11, Vol.11 (11), p.2826-2829

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double-blind placebo-controlled study

Pulmonary circulation, 2021-07, Vol.11 (3), p.1-8

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of lasmiditan for the acute treatment of perimenstrual migraine

Cephalalgia, 2022-12, Vol.42 (14), p.1467-1475

2022

Link zum Volltext

Verfügbarkeit prüfen

Su1818 EFFECT OF MIRIKIZUMAB ON CLINICAL AND ENDOSCOPIC OUTCOMES AFTER 1 ANTI-TNF FAILURE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-828-S-828

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(50)
Buchkapitel
(1)

Sprache

Englisch
(51)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Humans
(21)
Middle Aged
(13)
Adult
(11)
Male
(11)
Double-Blind Method
(10)
Treatment Outcome
(10)
Aged
(8)
Clinical Trials
(8)
Female
(8)
Lasmiditan
(8)
Neurosciences & Neurology
(8)
Clinical Neurology
(7)
Pediatrics
(7)
Migraine
(6)
Neurosciences
(6)
Phosphodiesterase 5 Inhibitors - Administration & Dosage
(6)
Tadalafil
(6)
Urology & Nephrology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

P932 Corticosteroid-sparing effect of mirikizumab for the treatment of moderately-to-severely active Ulcerative Colitis: Extended induction subgroup analysis from Phase 3 trial

Antenatal and perinatal factors influencing neonatal blood pressure: a systematic review

P901 Extended induction response over time in patients with moderately-to-severely active Ulcerative Colitis treated with mirikizumab in the LUCENT-1 and -2 trials

OP14 Effect of mirikizumab on clinical and endoscopic outcomes after 1 anti-TNF failure in patients with moderately to severely active Ulcerative Colitis

P568 Clinical relevance of baseline and change in Urgency Numeric Rating Scale score for mirikizumab treatment for Ulcerative Colitis

108 Impact of Endogenous Hormonal Status on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5mg for LUTS/BPH

778 Satisfaction with tadalafil or tamsulosin once daily for the treatment of LUTS/BPH: Treatment satisfaction scale questionnaire results from a randomized double-blind, placebo-controlled trial

Pharmacological treatment of women awaiting Surgery for stress urinary incontinence

Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial

Method of Blood Pressure Measurement in Neonates and Infants: A Systematic Review and Analysis

S917 Mirikizumab Achieved Comprehensive Disease Control in Patients With Ulcerative Colitis From Phase 3 LUCENT-1 and LUCENT-2 Trials

S913 The Addition of Bowel Urgency Improvement to the Achievement of Clinical Response and Remission Was Associated with Better Quality of Life in Patients with Ulcerative Colitis from Mirikizumab Phase 3 Trials

S915 The Addition of Bowel Urgency Improvement to the Achievement of Clinical Response or Remission Was Associated with Better Work Productivity in Patients with Ulcerative Colitis from Mirikizumab Phase 3 Trials

Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials

Treatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH): results from a randomised, placebo‐controlled study

Tolerability and Safety of Lasmiditan Treatment in Elderly Patients With Migraine: Post Hoc Analyses From Randomized Studies

Migraine history and response to lasmiditan across racial and ethnic groups

Time to Onset of Clinically Meaningful Improvement with Tadalafil 5 mg Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Analysis of Data Pooled from 4 Pivotal, Double-Blind, Placebo Controlled Studies

Lasmiditan in patients with common migraine comorbidities: a post hoc efficacy and safety analysis of two phase 3 randomized clinical trials

A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN

Lasmiditan efficacy in migraine attacks with mild vs. moderate or severe pain

Comparability of Single Measurements of Serum Testosterone to the 24‐Hour Cavg in Patients Using Testosterone 2% Solution

Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double-blind placebo-controlled study

Efficacy of lasmiditan for the acute treatment of perimenstrual migraine

Su1818 EFFECT OF MIRIKIZUMAB ON CLINICAL AND ENDOSCOPIC OUTCOMES AFTER 1 ANTI-TNF FAILURE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Suchergebnisse filtern